Article
Atrial Fibrillation and Bleeding in Patients With Chronic Lymphocytic Leukemia Treated with Ibrutinib in the Veterans Health Administration
- Author:
- Kelli M. Rasmussen, MS
- Vikas Patil, MS
- Zachary Burningham, PhD
- Christina Yong, MA
- Brian C. Sauer, PhD
- Ahmad S. Halwani, MD
Although ibrutinib is associated with increased bleeding-related adverse events, the risk for patients with chronic lymphocytic leukemia is...